https://www.africanewscurrents.com/article/911623471-no-entry-fee-share-600-000-zoomex-launches-the-world-s-first-zero-cost-trading-competition-let-skill-be-your-only-asset Africa News Currents en PressRelease 2026-05-09T11:09:31+00:00 No Entry Fee, Share $600,000! Zoomex Launches the World’s First Zero-Cost Trading Competition: Let Skill Be Your Only Asset https://ml.globenewswire.com/media/5b8a6c68-d7a0-46f2-9622-debed4948d0b/medium/zoomex.png https://www.africanewscurrents.com/article/911474191-fulcrum-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Africa News Currents en PressRelease 2026-05-08T20:30:00+00:00 Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.africanewscurrents.com/article/911474434-azalea-therapeutics-announces-late-breaking-oral-presentation-at-asgct-annual-meeting-demonstrating-first-in-primate-in-vivo-trac-car-t-cell Africa News Currents en PressRelease 2026-05-08T20:30:00+00:00 Azalea Therapeutics Announces Late-Breaking Oral Presentation at ASGCT Annual Meeting Demonstrating First-in-Primate In Vivo TRAC-CAR T Cell Engineering https://ml.globenewswire.com/media/074db8ed-c280-47d0-8c17-f1980e6b4ad3/small/azalea-therapeutics-logo-1200x353-png.png https://www.africanewscurrents.com/article/911474530-koryx-copper-files-technical-report-with-updated-mineral-resource-estimate-for-the-haib-copper-project-southern-namibia Africa News Currents en PressRelease 2026-05-08T20:26:17+00:00 Koryx Copper Files Technical Report with Updated Mineral Resource Estimate for the Haib Copper Project, Southern Namibia https://ml.globenewswire.com/media/0e99cc78-b80a-4380-a212-35e3ef8b9801/small/koryx-logo-lr-copie-png.png https://www.africanewscurrents.com/article/911474273-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Africa News Currents en PressRelease 2026-05-08T20:05:00+00:00 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.africanewscurrents.com/article/911474203-bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Africa News Currents en PressRelease 2026-05-08T20:01:00+00:00 BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.africanewscurrents.com/article/911474472-biofrontera-inc-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-on-may-14-2026 Africa News Currents en PressRelease 2026-05-08T20:00:00+00:00 Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026 https://ml.globenewswire.com/media/4af5197e-340e-4307-892b-382a1d29ae45/small/logo-png.png